Zynerba Pharmaceuticals Inc (ZYNE)

Saved. See Saved Items.

This comment has already been saved in your Saved Items

I'm not happy with the sale, it would have been better if the company continued the introduction and got off the ship after a successful FDA decision, then the $8 would have been fine, there is nothing to do but say goodbye to the comrades, good luck to everyone in other pharmaceuticals.

0 0

Kubizm Oct 11, 2023 10:25AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

bye bye Zyne.

0 0

Csaba Kiss Sep 16, 2023 10:04AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

On the day of the buyout offer, it was deposited at 1.37, it did not go away, I withdrew it the next day, there is no point in charting, here the news is measured at 300%, so the stop is not, either to give, or upon agreement when selling the patent protection, or the introduction request upon submission to the FDA. Zero still has a 10-20% chance, the rest shares the band between $2.5 and $10, for a company with 25 employees, if you manage to sell the license, the revenue will reach $1 billion around 2027-28, the royalty would be 20% , this story would not move anything at Pfizer, there are 83,000 employees. We have to wait for the sale of the Zygel distribution, in the form when the royalty payment is made every 1/4th year for 18 years, then we would see a day of +300% again, these $60 and +140 m promise little. Don't worry, don't watch the news, patience everyone!

0 0

Kubizm Sep 11, 2023 4:08AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

I found 3 lawfirms that are investigating potential Board's lack of diligence regarding Harmony deal since there are lots of milestones to achive for ZYGEL to get 140 mln additional price for shareholders. Acording to one of the annoucments there are certain guarantees for board members for theirs paychecks while extra payment for shareholders are gloomy regarding strict conditions for ZYGEL

0 0

Csaba Kiss Sep 11, 2023 4:08AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Slow down, Amigo, if they don't sell it, but sell it directly after the launch, then not $140m once, but even $200m royalties per year after traffic starts up for 15 years, when the protection expires, which is 18 years anyway, you're a beginner you are a competitor in this pharmaceutical profession, I will not take you on as a student-:)XD

0 0

Kubizm Sep 11, 2023 4:08AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Csaba Kiss just sayin if some is interested :)

0 0

Csaba Kiss Sep 06, 2023 2:51PM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

I hold it firmly, I have no intention of selling it, the next +300% day would be the submission of the FDA registration application, do the math, I assume a royalty transfer of $3/share for the sale of the distribution, 25 employees will not live up to it, a fabulous dividend would come, the current exchange rate double, there is still the possibility of a fall, but the chance of this has greatly decreased. Patience everyone, it's a patience game now.

0 0

Csaba Kiss Aug 14, 2023 11:55AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Írja I looked at ZYNERBA as either zeroing out, maybe 10x, it is working on the launch of an ointment containing cannabis, in relation to rare mental illnesses, the launch was promised next year, I considered it possible to reach even $1 billion in revenue, if it were to sell, then 3 years after the launch after peaking, $200 million/year in royalties would arrive. Today, the hard rock hit, a buyout offer of $1.1059 in cash + $140 million in milestones upon successful launch, Cash/share 84 cents, it also traded at an abnormal 30 cents, 1/3 of the stock, so the buyer would only pay 26 cents including kp, working capital covers short-term liabilities 5x, it can last until the introduction, if it comes together at the FDA, then + 140 is in play, which is 3x even from here, exchange rate +277% now, but the real big money, 3x would also multiply , if they don't give it and sit in the gold mine. I've always loved and felt for pharmaceuticals, until now Cariprazine launch in September 2015, Allergan buyout, BIOGEN Alzheimer's story, this would be the icing on the cake.meg véleményét a Zynerba Pharmaceuticals Inc.-ről

0 0

Kubizm Aug 10, 2023 9:14AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

haha ZYNE can't push reverse stock split because of the absence of shareholders on meetings xD Zyne became garbage stock

2 0

Csaba Kiss Aug 10, 2023 9:14AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

-:)XDDDDDDDDDD

1 0

Kubizm May 17, 2023 10:06AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Zynerba intends to seek approval of a reverse stock split at its Annual Meeting of Stockholders in June (Annual Meeting), which it would effect any time prior to November 1, 2023. Details of the reverse stock split are included in the Company’s Proxy Statement for the Annual Meeting. The primary objective of implementing a reverse split is to satisfy the minimum bid price requirement for continued listing on the Nasdaq Capital Market. The Company’s Board believes that effecting the reverse split would increase the price of our common stock which would, among other things, help the Company to: Meet certain continued listing requirements of the Nasdaq Capital Market; Appeal to a broader range of investors to generate interest in the Company; and Improve perception of the Company’s common stock as an investment security.

0 0

Kubizm May 17, 2023 10:06AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

long story short, zyne performes so "good" that would be delisted

0 0

Kubizm May 16, 2023 7:55AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

and now money burs faster and faster bye bye zyne

0 0

Равиль Зайнуллин Mar 13, 2023 8:03AM ET

Follow this post

Unfollow this post

Saved. See Saved Items.

This comment has already been saved in your Saved Items

🤮🤮🤮🤮

0 0